OptimizeRx Corp. published its Environmental, Social, and Governance (ESG) report for 2025, detailing its commitment to corporate citizenship. The report highlights the company's efforts across various ESG topics.
A notable achievement is the improvement in its Institutional Shareholder Services (ISS) ESG rating, moving from the seventh decile to the first decile. This improvement earned OptimizeRx 'prime status' from ISS ESG.
The report covers governance, planet, people, and prosperity initiatives, showcasing enhanced disclosures on these areas. This transparency aligns with stakeholder expectations regarding the company's responsibilities.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.